Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Brozek (Katowice, Poland), N. Nowak (Czosnow k Warszawy, Poland), J. Mateusz (Katowice, Poland), J. Zejda (Katowice, Poland). The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations?. 1164

Member's Comments

No comment yet.

Related content which might interest you: The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients. Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014 Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 GOLD 2011 versus GOLD 2017 – What does change? Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Differences in the recommended initial therapy of COPD according to GOLD guidelines 2006 and 2011 Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Symptomatic assessment in COPD GOLD 2011 classification - mMRC/CAT agreement Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016 High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 The 2006 and 2011 GOLD classifications and five-years mortality in COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 New GOLD 2011 guidelines: Is there an improvement? Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012 GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 COPD comorbidities and risk assessment according to GOLD 2011 revision Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 COPD: GOLD 2011 and implications for clinical practice Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 The 2013 updated GOLD strategy: A comparison of the various scenarios Source: International Congress 2014 – Best abstracts in chronic care Year: 2014 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 New GOLD recommendations in a seven years follow up - changes in symptoms and risk categories Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality? Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014 Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011? Source: Eur Respir J 2014; 43: 1201-1203 Year: 2014